Ginsenoside Rg1 improves survival in a murine model of polymicrobial sepsis by suppressing the inflammatory response and apoptosis of lymphocytes
Authors:
- Tianzhu TaoTTTianzhu Tao
- Ye TianYTYe Tian
- Jiali ZhuJZJiali Zhu
- Lijun CaoLCLijun Cao
- Xiaoming DengXDXiaoming Deng
- Jinbao LiJLJinbao Li
- 1 August 2013
- journal article
- Published by Elsevier in Journal of Surgical Research
- Vol. 183 (2) , 760-766
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 35 references indexed in Scilit:
- Ginsenoside-Rg1 Protects the Liver against Exhaustive Exercise-Induced Oxidative Stress in RatsEvidence-Based Complementary and Alternative Medicine, 2012
- Immunosuppression in Patients Who Die of Sepsis and Multiple Organ FailureJAMA, 2011
- Advances in the Management of Sepsis and the Understanding of Key Immunologic DefectsAnesthesiology, 2011
- Ginsenoside Rg1 modulation on thrombospondin‐1 and vascular endothelial growth factor expression in early renal fibrogenesis in unilateral obstructionPhytotherapy Research, 2010
- Sepsis biomarkers: a reviewCritical Care, 2010
- Pharmacology of ginsenosides: a literature reviewChinese Medicine, 2010
- Mitogen‐activated protein kinase (MAPK) pathway mediates the oestrogen‐like activities of ginsenoside Rg1 in human breast cancer (MCF‐7) cellsBritish Journal of Pharmacology, 2009
- Mechanisms of Mortality in Early and Late SepsisInfection and Immunity, 2006
- 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions ConferenceIntensive Care Medicine, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003